Objective
HeartRepair uses the lessons of the embryo to answer the crucial developmental questions regarding heart muscle cell differentiation and develop techniques aimed at harnessing stem cells and or recruiting non-damaged myocardial cells from the infarcted heart to facilitate cardiac repair.
Myocardial infarction is the leading cause of congestive heart failure mainly caused by excessive smoking and bad dietary habits. However, the cause of the subsequent heart failure is simple, massive cardiomyocyte necrosis which fatally perturbs heart function. However, an effective therapeutic approach is simple: replacement of damaged myocardium with viable cardiomyocytes.
Recent advances in the field of stem cell replacement therapies, specifically cardiomyocyte regeneration, gains grace as a realistic alternative for congestive heart repair. Major publications revolve around transplantation trials carried out using either embryonic stem cells or bone marrow derived stem cells. However, Field serious questions the current scientific approach to this research and more importantly if, using current techniques and knowledge, such a goal can realistically ever be reached. Realization of this aim will only be achieved by understanding the underlying principles of cardiac muscle cell formation; the mission statement of HeartRepair.
HeartRepair addresses four R&D themes:
1. Genes for heart repair and plasticity, integrating clinical knowledge based genome sequencing to identify genes involved in heart development;
2. Diversification of cardiac progenitor cells, examining the genetics of cardiac muscle cell formation by exploring the process of cardiomyogenesis and subsequent differentiation;
3. Cell interaction and cardiac reprogramming, exploring the details and signals necessary to facilitate an redirect the cardiac fibroblast cell lineage for repair recruitment;
4. Cardiac rejuvenation, to develop techniques to facilitate and speed repair of damaged, not yet necrotic.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- medical and health sciencesclinical medicinecardiology
- medical and health sciencesclinical medicinetransplantation
- medical and health sciencesclinical medicineembryology
- natural sciencesbiological sciencesgeneticsgenomes
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Call for proposal
FP6-2004-LIFESCIHEALTH-5
See other projects for this call
Funding Scheme
IP - Integrated ProjectCoordinator
AMSTERDAM
Netherlands
See on map
Participants (21)
MÜNCHEN
See on map
NEWCASTLE UPON TYNE
See on map
N/A HEIDELBERG
See on map
PARIS
See on map
PARIS
See on map
ROMA
See on map
MILAN
See on map
LONDON
See on map
JAEN
See on map
HANNOVER
See on map
UTRECHT
See on map
MÁLAGA
See on map
9503 LEIDEN
See on map
ZURICH
See on map
GOTHENBURG
See on map
FRANKFURT
See on map
PADOVA
See on map
300 THE HAGUE
See on map
MADRID
See on map
E-28029 MADRID
See on map
BERLIN
See on map